Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about BMRN

Recent news which mentions BMRN

< Previous 1 2 3 4 5 6 7 8 Next >

BioMarin Sells Priority Review Voucher For $110M

February 09, 2022

12 biotech stocks to consider buying now as prospects for the sector brighten this year

February 06, 2022

BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis

January 10, 2022

2 Under-the-Radar Biotech Picks to Buy For The Long Haul

December 24, 2021

This Favorable Sign Appears On Biomarin Pharmaceutical's Chart

November 25, 2021

Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart

November 24, 2021

Where Biomarin Pharmaceutical Stands With Analysts

November 22, 2021

Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021

November 22, 2021

10 Biggest Price Target Changes For Monday

November 22, 2021

Why BioMarin Pharmaceutical Stock Jumped by 10.3% on Friday

November 20, 2021

FDA Conditionally Approves Biomarin's Dwarfism Drug

November 19, 2021

Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?

November 18, 2021

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

November 14, 2021

Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates

November 02, 2021

BioMarin's Q3 Net Income Hit By Lower Product Sales

October 28, 2021

BioMarin Pharmaceutical inc (BMRN) Q3 2021 Earnings Call Transcript

October 28, 2021

Biomarin Pharmaceutical: Q3 Earnings Insights

October 27, 2021

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

October 24, 2021

2 Upcoming FDA Approval Decisions That Investors Should Really Watch

October 23, 2021

The Smartest Stocks to Buy With $250 Right Now

October 22, 2021

Barron's Latest Picks And Pans: Amazon, Apple, Chevron, Citigroup, Dell And More

October 16, 2021

Stifel Upgrades This Pharma Stock On Prospective FDA Approval For Dwarfism Drug

September 09, 2021

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021

September 09, 2021

Price To Earnings Ratio Insights For Biomarin Pharmaceutical

September 07, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

September 07, 2021

FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder

September 07, 2021

Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval

August 27, 2021

Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months

August 20, 2021

BioMarin Bounces Back With Solid Q2 Earnings, Nudges Up 2021 Guidance

July 29, 2021

BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript

July 29, 2021

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.